FDA Fast-Tracks AI Adoption to Transform Drug Review Process
FDA Commissioner Martin Makary has directed all FDA centers to implement artificial intelligence across the agency by June 30, 2025, following a su...
FDA Commissioner Martin Makary has directed all FDA centers to implement artificial intelligence across the agency by June 30, 2025, following a su...
Piper Sandler has raised its price target for Tempus AI (NASDAQ:TEM) from $55 to $70, while maintaining a neutral rating on the stock. The increase...
FDA Commissioner Martin Makary announced an aggressive timeline to implement artificial intelligence across all FDA centers by June 30, 2025, follo...